Ping An

Ping An Insurance (Group) Company of China, Ltd., established in 1988 in Shenzhen, is a leading personal integrated financial services provider in China. As the first insurance company in the country to adopt a shareholding structure, Ping An has evolved to encompass three core businesses: insurance, banking, and investment. The company aims to foster the parallel growth of its traditional and non-traditional financial ventures. In its traditional business, Ping An focuses on creating a financial supermarket and enhancing customer migration. Concurrently, it seeks to innovate within non-traditional sectors by seamlessly integrating financial services into everyday life, covering areas such as health, housing, and entertainment. The Group strives to establish an integrated financial services platform that offers a comprehensive customer experience, promotes sustainable profit growth, and ensures long-term stability for its shareholders.

Mingzhe Ma Ph.D

Chairman and CEO

Hui Zhou

Partner

123 past transactions

Soterea

Series B in 2022
Soterea is a software company that develops an intelligent driving system for commercial vehicles. It was founded in 2014 and is based in Tianjin, China.

Rain Med

Series D in 2021
Rain Med is a vascular interventional surgical robot developer focused on the development of coronary angiography systems.

Xgene Pharmaceutical

Series C in 2021
Xgene Pharmaceutical is a late-clinical stage, venture-backed international company that uses proprietary linker technology to develop novel, multimodal conjugated molecules for the treatment of neurological disorders. Current programs are aimed at increasing the efficacy and tolerability of pain medications.

Biren Technology

Series B in 2021
Biren Technology is a high-tech startup that has the niche in softwares, hardwares, and chip system. The niche software department is led by the industry's top talents, composed of field technical experts and software elite engineers. The niche hardware department is committed to building a wide range of computing solutions based on general computing, combining versatility and specificity. As a frontier research department of the niches, the Institute aims to study the key technologies of new intelligent computing systems, focusing on new architectures and advanced compilation technologies.

Apollomics

Series C in 2020
Apollomics is a developer of oncology therapeutics intend to harness the immune system and targeting specific molecular pathways.The company's therapeutics target the growth and proliferation of cancer cells and offer an oral c-Met inhibitor that restores the body's immune system to recognize and kill cancer cells, enabling clients to treat their patients in an enhanced way.

Lepu Bio

Series B in 2020
Lepu Bio they have developed an oncology-focused pipeline of drug candidates, including ADCs, oncolytic virus drugs, and immunotherapies at clinical and pre-clinical stages.

DentaLink China

Series C in 2020
Developer of dental imaging technology and dental clinic management software. The company's software helps dental professionals accurately diagnose patient conditions through oral CT scanning, as well as keep track of patient records and appointments, enabling dental professionals to provide treatment more efficiently.

Wind

Funding Round in 2019
Wind Information is recognized as the leading firm in financial data, information services and solutions in China. We are dedicated to providing accurate and real-time data, as well as sophisticated information platforms for financial professionals.

Lixiangjia

Series D in 2019
The professional global Chinese overseas asset reconfiguration consulting service platform is dedicated to providing one-stop overseas asset product information support services for Chinese wealth management practitioners. It has set up branches in many cities across the country to provide institutions, financial planners and medium and high net worth families. Professional overseas asset reconfiguration plan.

Shijiazhuang Junlebao Dairy

Funding Round in 2019
Shijiazhuang Junlebao Dairy is a prominent dairy products company based in China, specializing in a diverse array of offerings that include fluid milks, flavored milk, yogurt, baby formula, and milk powder. The company has developed a comprehensive operational framework that encompasses the entire dairy industry chain, ensuring coordinated development and a focus on nutrition, health, and safety for its consumers. By prioritizing quality and innovation, Junlebao Dairy aims to meet the growing demand for dairy products in the market while promoting the well-being of its customers.

ITutorGroup

Acquisition in 2019
ITutorGroup provides online education platforms for students and business professionals. Its products include VIPABC, TutorABC, VIPABCJr, and TutorABCJr for English-language learning, TutorMing for Mandarin Chinese language learning, and LiveH2H for live translations in multiple languages. Eric Yang, Jerry Huang, and Ming Yang founded ITutorGroup in 1998, with headquarters in Taipei City in Taiwan. It has additional offices in Shanghai in China and Santa Clara in California.
Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.
Global Data Solutions designs, builds, and operates data centers in the People's Republic of China together with its subsidiaries. It provides colocation, managed hosting, and managed cloud services, as well as consulting services. Global Data Solutions's data centers service customers that primarily operate in the Internet and banking industries in Shanghai and Beijing municipalities; and Jiangsu, Guangdong, Sichuan, and Hebei Provinces. It serves cloud service providers, Internet companies, financial institutions, telecommunications and IT service providers, and large domestic private sector and multinational corporations. William Wei Huang founded Global Data Solutions in 2000. It has its headquarters in Shanghai in the People's Republic of China.

Zhangshang Tangyi

Series C in 2019
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Xiaoqule

Series A in 2018
Xiaoqule (Happy Community) is a Chinese community-focused e-commerce platform. It is a subsidiary of Gejia. Xiaoqule helps local businesses provide cost-effective products and services to the local community. On the platform, the consumer can order food such as seasonal fruits and vegetables from local businesses. Xiaoqule connects local businesses with local consumers, which shortens transportation time and maintains quality of goods. Xiaoqule also serves as a logistical company, providing transportation, technology, marketing and customer support.

Global Scanner

Series A in 2018
Global Scanner is a social e-commerce platform targeting the middle-class in China.

NextCure

Series B in 2018
NextCure is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.

Xgene Pharmaceutical

Series B in 2018
Xgene Pharmaceutical is a late-clinical stage, venture-backed international company that uses proprietary linker technology to develop novel, multimodal conjugated molecules for the treatment of neurological disorders. Current programs are aimed at increasing the efficacy and tolerability of pain medications.
Lenovo Healthcare is a cloud-based smart medical solution company for medical institutions.
Jin Jiang Environmental Holdings Limited is China's leading waste to energy operators.The company has successfully embarked on a road of environmentally-friendly energy industrialization that combines production, learning

Chemclin

Private Equity Round in 2018
Chemclin Biotech is a Chinese technical service provider that is focused on in-vitro diagnostic instruments and auxiliary reagents for clinical diagnosis. Chemclin Biotech’s service covers clinical inspection instruments, auxiliary reagents (chemiluminescence, biochemical, exemption), technical services, management and certification, independent medical laboratories, and more. The company is dedicated to the introduction of diagnostic products and services to the Chinese market.

Grab

Series H in 2018
Grab operates a mobile technology platform that integrates city transportation for driver-partners and customers in South East Asia. It offers services like GrabTaxi, GrabCar, GrabHitch, GrabShare, GrabCoach, GrabShuttle, GrabShuttle Plus, GrabFamily, JustGrab, GrabNow, and GrabRental. Grab offers services in Singapore, Indonesia, Philippines, Malaysia, Thailand, Vietnam, and Myanmar. Anthony Tan and Tan Hooi Lng founded it in 2012 and is headquartered in Singapore. It has additional offices in Seattle, Beijing, Bangalore, Jakarta, and Vietnam.

HashFish

Angel Round in 2018
HashFish provides bitcoin mining software and services.

Jollychic

Series C in 2018
Jollychic is a one-stop e-commerce platform sells clothing and accessories online. Jollychic engages in the online retail of garments, shoes, bags, stationeries, pen, paper, babywear, baby accessories, sports goods, car electronics, plush and dolls, toys, bedding sets, wedding supplies, cleaning tools, storage racks, storage boxes, housewares, and kitchen appliances. Aaron Li founded it in 2012, with its headquarters in China.

Tmunity

Series A in 2018
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells to treat a wide range of disease indications. Tmunity is developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms that exhibit best-in-class control over T cell activation and direction in vivo, as well as proprietary technologies to activate, expand, and genetically engineer T cells from peripheral blood, cord blood and tumors. The company is rapidly advancing toward the clinic personalized next-generation immunotherapies for oncology, infectious diseases and autoimmune disease. The founding team includes experts in T-cell biology, manufacturing, regulatory affairs, and clinical development, who collectively have an unparalleled track record of executing safe and effective cell and gene therapy clinical trials. In addition, Tmunity’s manufacturing platform has a proven track record of success in supporting multi-center clinical studies across diverse therapeutic indications.

Hua Medicine

Series D in 2018
Hua Medicine is a clinical-stage, innovative drug development company in China, focused on novel therapies for the treatment of diabetes and CNS disorders. Founded by pharma industry veterans and funded by a premier group of international VC investment firms such as Fidelity Asia, Fidelity Biosciences, ARCH Ventures, Venrock, SAIL and WuXi Ventures, the company has in-licensed from major pharma, world-wide rights to a potential best-in-class, oral drug for the treatment of Type 2 Diabetes which utilizes a novel mechanism of action.

Rani Therapeutics

Venture Round in 2018
Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes. They developed the RaniPill capsule, which is Rani's novel, proprietary, and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The RaniPill capsule is an orally ingestible pill approximately the size of a “000” capsule (or similar to the size of a standard fish oil or calcium pill) that is designed to automatically administer a precise therapeutic dose of medication upon deployment in the small intestine. To date, Rani has successfully conducted several preclinical and clinical studies to evaluate safety, tolerability, and bioavailability using the RaniPill capsule. Their development efforts have enabled them to construct an extensive intellectual property portfolio that they believe provides patients with a competitive advantage.

TytoCare

Series C in 2018
TytoCare is a mobile-health platform and device, that allows anyone to perform self-physical examination and remote diagnosis. Tyto Care has three telehealth products: the TytoHome for consumers, TytoPro for professionals, and TytoClinic for remote point-of-care locations. All solutions are designed to replicate a facetious clinician visit and include a modular examination tool for examining the heart, lungs, skin, throat, ears, and body temperature; a complete telehealth platform for sharing exam data, conducting live video exams, and scheduling visits; a cloud-based data repository with analytics; and built-in guidance technology and machine learning algorithms to ensure accuracy and ease of use.

Tmunity

Series A in 2018
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells to treat a wide range of disease indications. Tmunity is developing novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms that exhibit best-in-class control over T cell activation and direction in vivo, as well as proprietary technologies to activate, expand, and genetically engineer T cells from peripheral blood, cord blood and tumors. The company is rapidly advancing toward the clinic personalized next-generation immunotherapies for oncology, infectious diseases and autoimmune disease. The founding team includes experts in T-cell biology, manufacturing, regulatory affairs, and clinical development, who collectively have an unparalleled track record of executing safe and effective cell and gene therapy clinical trials. In addition, Tmunity’s manufacturing platform has a proven track record of success in supporting multi-center clinical studies across diverse therapeutic indications.

KBP Biosciences

Series A in 2018
KBP is a world-class biotechnology research & development organization dedicated to providing innovative therapies for unmet medical needs.

StartUp Health

Venture Round in 2018
StartUp Health is investing in a global army of Health Transformers to achieve health moonshots. StartUp Health is on a 30-year mission to collaborate with entrepreneurs to improve the health and wellbeing of everyone in the world. Since 2011, StartUp Health has been investing in a global army of entrepreneurs -- called Health Transformers -- to achieve health moonshots: Access to Care, Cost to Zero, Cure Disease, End to Cancer, Women’s Health, Children’s Health, Nutrition and Fitness, Brain Health, Mental Health and Happiness, Addiction, Longevity, and Pandemic Response. StartUp Health has the world’s largest health innovation portfolio with more than 330 companies across six continents and 26 countries and is backed by leading investors including Advocate Aurora Health, Chiesi, Steve Case, Mark Cuban, Esther Dyson, Brad Feld, GuideWell, Jason Finger, Jerry Levin, Kaiser Permanente, Masimo, Novartis, Otsuka, and Ping An.

Rogrand

Series C in 2017
Beijing Rogrand E-Commerce Co., Ltd. is a leading pharmaceutical entire integration of industry chain service platform in China leading the innovation of new pharmaceutical business model. Since its inception in 2012, the company has always been driven by the goal of forging a circulation platform for the whole industry consisting of pharmaceutical industry, pharmaceutical business, pharmacy, clinic and medical institution.

Chexiang

Series B in 2017
Chexiang.com is a Chinese online-to-offline automotive trading platform under Shanghai-based auto maker SAIC Motor Co Ltd.

Fullerton Healthcare Corporation

Venture Round in 2017
Fullerton Health is a leading provider of corporate healthcare solutions across Asia Pacific with more than 225 fully-owned medical centres, a network of more than 8,000 medical providers, 2,000 employees including more than 1,200 healthcare professionals, and six call centres across five countries.

Tikin Media

Angel Round in 2017
Tikin Media is a forward-looking advertising company that innovates building elevator media. The shareholders are composed of the world's top 500 and well-known media groups. They were successively invested by Baidu Venture Capital, Sequoia China and IDG within one year. Since its inception, the company has positioned itself to be a “high-end commercial building effect media operator”. The company's self-developed and possessed intellectual property elevator projection equipment is a new media form that subverts existing planar communication media, realizes mobile interconnection, and has programmatic ordering and big data analysis functions.

Annoroad

Series C in 2017
Annoroad Gene Technology, founded in 2012 with headquarters in Beijing, is a well-known enterprise in China’s genomics industry, a leading NIPT service provider in China, and a best-in-class medical genomics center in Asia, which specializes in the application of next-generation genomics in human health and life science research. Since its founding, Annoroad has been recognized with a series of prestigious designations including national high-tech enterprise, one of the pilot organizations approved by the NHFPC (National Health and Family Planning Commission) to take part in the high-throughput sequencing clinical application, one of the first gene detection technology demonstration centers approved by the NDRC (National Development and Reform Commission), one of the Beijing Engineering Laboratory of Precision Medicine and Genetic Engineering approved by Beijing Municipal Development and Reform Commission, one of the enterprises included in the Beijing Biopharmaceutical Industry Leap-forward Development Program (G20 Program), Beijing ScientiÞ c and Technological R&D Institution. It has a post-doctoral scientiÞ c research station and is included in Top 30 Leading Technology Companies in China, and Top 50 Most Investment-Worthy Enterprises in China. Based on its core overseas and domestic talent teams, Annoroad has developed leading proprietary genome sequencing and bioinformatics technologies and established advanced high-throughput sequencing and high-performance computing platforms. Annoroad has launched NextSeq 550AR (CFDA No.:20173400330), a leading high-throughput benchtop sequencer, and SolarGenomics, a cloud-based genomic big data platform. Currently, Annoroad has put in place a comprehensive product system covering sequencing instrument and reagents, medical testing and research, scientific research service, Genomic big data service with a high reputation and built a strong presence along the upstream, midstream and downstream of the entire industry chain and powerful Bio-IT industrial service capabilities, which have been highly recognized by a wide range of partners.

Prenetics

Series B in 2017
Prenetics is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the top sports distribution companies in the USA. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by ‘enhancing life through science’.

Che Youyuan

Series A in 2017
Che Youyuan provides assistance services to the majority of car owners at any time, any place, and any vehicle. Rescue service products and peripheral products include towing service, telephone service, tire replacement service, field repair, dianbao, multi tool pen, and rescue t-shirt

Huya.com

Series A in 2017
Huya.com is China's interactive broadcast platform, enriched by the world's first communications service operators. The company's live products cover PC, Web, and mobile three-end, and have nearly 300 featured channels in 4 categories including online games, single-game hot games, mobile games, and entertainment variety, covering e-sports, music, sports, beauty, outdoor, A wide range of popular content such as reality shows, variety shows, entertainment, and food.

AIQI Technology

Series A in 2017
Beijing AIQI Technology Co.,Ltd. is an Internet technology company concentrating on the research and development in the field of Artificial Intelligent and Robotic Technology. They gathered a grounp of energetic, curious, creative and ambious young people together to explore this chanllengeing world. In the lastest three years, they acquired a great number of patents in area of intelligent equipment. Very excitingly, they estabished cooperation with the technical giant XIAOMI and become the only company of DIY Intelligent Robot in XIAOMI's Ecosystem Strategy. Armed with a powerful research team, the advanced technology, the superb production ability, they successfully put out their DIY intelligent interactive robots who are ease to use, able to update, AI intergrated and creativity inspiring. They devote themselves to provide endless fun for everyone in modern life.

Global Switch

Secondary Market in 2016
Global Switch own and operate around 3,000,000 sq ft (278,700 sq m) of exceptional, wholesale and multi tenanted, carrier neutral data centre space across Europe and Asia-Pacific. Established in 1998 their longevity in the market place and impressive track record prove they deliver best in class solutions.

Taptap

Series A in 2016
TapTap is a community game, is also a platform game download purchase.

Innovent Biologics

Series D in 2016
Innovent Biologics, Inc. is a privately held biopharmaceutical company dedicated to developing and manufacturing monoclonal antibodies to be marketed in China and elsewhere around the world. Innovent is funded by Fidelity's venture arm, a prominent investment firm in the US, Lilly Ventures, and Suzhou bioBay. The registered capital is 30 million US Dollars. The founders and senior management team of Innovent have over 70 years of combined work experience in the discovery, development, and manufacture of biologics in the US, Europe, and worldwide and were involved in the launch of such products as Bexxar, Conbercept, Natrecor, Oncorine, Recombivax HB, and others.

Gegejia.com

Series A in 2016
Gege home, under the Zhejiang Grid Network Technology Co., Ltd., focused on imported food sales, on-line time March 26, 2015, on-line orders within 30 days more than 10,000 single orders for millions of dollars. Gege home core team all have 5 years to 10 years of e-commerce-related experience, and a strong accumulation of industry resources.

Fe3 Medical

Series B in 2016
Fe3 Medical Inc. engages in commercialization of a drug delivery technology that enables the safe, non-toxic transport of approximately 10 milligrams of iron across the skin for those who suffer with iron-deficiency anemia.

Nanopep

Seed Round in 2016
Nanopep is a nano-biomedical high-tech company. They develop platform technology to enable personalized medicine, such as SPRI and MALDI-TOF MS microarrays for massively parallel peptide screening, and an efficient platform for the enrichment of circulating tumor cells using nano-beads. The company claims that the latter technology will power its protein-based liquid biopsy assay.

Wanjia

Angel Round in 2016
Wanjia provides dentistry, chinese medicine, pediatrics, and gynaecology services. They provide services for children and adults. Their customers' inquiries are addressed through phone, email, and online applications.

Zhuanhua Yixue Wang

Series A in 2016
Zhuanhua Yixue Wang is a translational medicine portal for gene testing, cell therapy, in vitro diagnosis, precision medicine, and other core segments of translational medicine that provide original content and in-depth industry analysis. They provide news reports for doctors, researchers, enterprises, and related practitioners with the goal of leading the development of the industry. They offer services for forums, salons, and training courses.
Fabric Genomics is making genomics-driven precision medicine a reality. We provide clinical decision support software that enables clinical labs, hospital systems and country-sequencing programs to gain actionable genomic insights, resulting in faster and more accurate diagnoses and reduced turnaround time. Fabric’s end-to-end genomic analysis platform incorporates proven AI algorithms, and has applications in both hereditary disease and oncology. Headquartered in Oakland, California, Fabric Genomics was founded by industry veterans and innovators with a deep understanding of bioinformatics, large-scale genomics and clinical diagnostics.

Applied StemCell

Series D in 2016
Applied StemCell Inc. (ASC) is a fast growing biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics. Using our proprietary TARGATT™ gene modification technology, we make site-specific Knockin mouse, rat and human cell line models fast and efficient for pharmaceutical and academic community. Based on our Proprietary Technologies, we focus on the development and commercialization of: Mouse models (Knockin, Knockout, Transgenic, Site-specific transgenic - TARGATT™, Humanized mouse models) Rat models Human cell line model (Gene modified iPSC - adult stem cell / progenitor cells - differentiated cells) Stem cell culture products (optimized stem cell medium and reporters) Gene engineering in stem cells or other mammalian cells (e.g. generation of protein - production mammalian cell lines) We are striving to improve and expand our technologies and product lines to meet the increasing requirements of biomedical community. ASC welcomes your comments, suggestions and ideas.

Rogrand

Series B in 2016
Beijing Rogrand E-Commerce Co., Ltd. is a leading pharmaceutical entire integration of industry chain service platform in China leading the innovation of new pharmaceutical business model. Since its inception in 2012, the company has always been driven by the goal of forging a circulation platform for the whole industry consisting of pharmaceutical industry, pharmaceutical business, pharmacy, clinic and medical institution.

Shenchu Jia Yan

Angel Round in 2016
Shenchu Jia Yan is an online restaurant reservation platform.

F-ROAD

Series E in 2016
F-Road provides network identity technology operation and financial inclusive technology operation services. They assisting the transformation and upgrading of regional banks, activating rural grassroots financial organizations, and practicing inclusive finance. They use big data, cloud platforms, and artificial intelligence technology to provide regional banks with two platforms and one service technology system, including a local life platform; smart credit platform; eID operation service.

Autohome

Acquisition in 2016
Autohome Inc. is the leading online destination for automobile consumers in China. Through their two websites, autohome.com.cn and che168.com, they provide comprehensive, independent and interactive content to automobile buyers and owners. Autohome.com.cn ranked first among China's automotive websites and automotive channels of internet portals in terms of average daily unique visitors, average daily time spent per user and average daily page views in 2013, according to iResearch, a third-party research firm. Their ability to reach a large and engaged user base of automobile consumers have made them the preferred platform for automakers and dealers to conduct their advertising campaigns. Automakers typically utilize their advertising services for brand promotion, new model releases and sales promotions. Their dealer subscription services allow dealers to market their inventory and services through their websites, extending the reach of their physical showrooms to potentially millions of internet users in China.

Meidaila1221

Series B in 2016
Meidaila is a computer software company offering technology solutions.

Prenetics

Series A in 2016
Prenetics is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, one of the top sports distribution companies in the USA. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by ‘enhancing life through science’.

Fe3 Medical

Series B in 2016
Fe3 Medical Inc. engages in commercialization of a drug delivery technology that enables the safe, non-toxic transport of approximately 10 milligrams of iron across the skin for those who suffer with iron-deficiency anemia.

JMDNA

Series B in 2016
JMDNA is a high-tech enterprise focusing on new technology research and clinical application in the field of women and children. It provides comprehensive, individualized, and precise genetic testing services for medical institutions and industry partners.

Oscar Health

Private Equity Round in 2016
Oscar is a health insurance company that offers individual and family plans, medicare advantages, and small group products. It employs technology, design, and data to humanize health care. The company offers plans to individuals, couples, and families living in parts of New York, New Jersey, California, and Texas who don’t receive health insurance from an employer. In 2012, Joshua Kushner, Kevin Nazemi, and Mario Schlosser headquartered Oscar Health in New York, New York.

YICHUAN

Angel Round in 2016
YICHUAN is a men's lifestyle media services company.

Bochewang

Series B in 2016
Bochewang is a professional B2B trading platform for motor cars and accessories, offering a plethora of vehicle sources, accessories, and high-quality services to professional buyers such auto repair shops, dismantle shops, used car dealers, and parts sellers. The auction center, automobile showroom, and accessories platform are the three main sections of the Bochewang Auction App. Members can use the auction center to sell accident automobiles and used cars, trade repaired used cars in the vehicle showroom, and trade various sorts of auto parts on the accessories platform. To enjoy numerous services and rights, users only need to complete registration, payment, and authentication.

20/20 Gene Systems

Series A in 2016
20/20 GeneSystems (‘20/20’) was founded in May of 2000 to develop and promote an innovative proteomics product line that provides drug companies, biodefense specialists and life scientists with new tools for protein analysis. Their headquarters are in the heart of the biotechnology corridor in Rockville, Maryland in close proximity to the National Institutes of Health with which they have extensive collaborations. 20/20 GeneSystems develops and commercializes innovative, proprietary diagnostics tests that aid in the fight against cancer. These tests generally fall into three categories: - Personalized Medicine: Their patented platform technology for measuring biomarkers in tumors is highly unique in that it combines the visual advantages of classical pathology with the multiplex capabilities needed as a result of genomics and proteomics. This technology is now being used to develop tests to predict responses to several new targeted therapies for kidney and lung cancer. - Early detection of lung cancer: 20/20 is developing a blood test for the early detection of lung cancer. This product will be used for screening smokers and former smokers to pre-select or enrich the patient population to receive annual CT scanning long before the disease becomes symptomatic. - Biological Detection: 20/20 is on the leading edge of developing technologies to help in the detection of biological toxins.

Zhangshang Tangyi

Series B in 2016
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Xieche.com

Series B in 2016
Xieche is a provider of automobile maintenance and repair services for car owners. They cover various car repair and maintenance projects such as sheet metal painting, electromechanical repair, and maintenance. They provide car maintenance services of maintenance at home, and repair at the store.

Kangzhi Pifuyisheng

Series A in 2015
Kangzhi Pifuyisheng is an online consultation service platform.

ALCHEMY INFORMATION

Angel Round in 2015
ALCHEMY INFORMATION provides game art services to the games industry. They specialize in 3D art production, 3D/2D animation, 3D/2D concept, and VFX for PC, AAA consoles, and mobile titles.

Black & White Campus

Series A in 2015
Black and White Campus offers campus promotion activities.

MOGU

Series E in 2015
MOGU is an consumer platform aimed towards women, achieved through e-commerce, social media, influencers and content driven services. Their content covers all areas of the fashion world and they have a huge range of age groups and interest covered through their numerous apps and platform. MOGU Inc. is a destination of fashion. With various kinds of fashion content and abundant fashion products, MOGU Inc. allows people to discover and share fashion trends while fully enjoying high-quality shopping experience. In 2011, MOGU Inc. launched fashion platform under the Mogujie brand . In 2016, the merger of Mogujie and Meilishuo was completed.Currently, MOGU Inc.'s online platform includes Mogujie.com and Meilishuo.com websites, mogujie mobile app, Meilishuo mobile app, Uni mobile app and several WeChat Mini programs.

Anxin Doctor

Series A in 2015
Anxin Doctor is a mobile maternal and pediatric health platform that connects patients with obstetrics, gynecology doctors and pediatrics doctors.

NCARS

Angel Round in 2015
NCARS provides chain services such as machine repair, body spraying, insurance, and accident vehicle. They offer brand marketing management, accessories supply chain, technician training, and service management.

Rakunew

Corporate Round in 2015
Rakunew is an e-commerce company that offers a range of gadgets and new products that are popular overseas. The company is an international mail-order company that sells innovative household items and gadgets that are well-liked abroad but hard to find in Japan.

Qukaidan

Series B in 2015
Enterprise service

58 Daojia

Series A in 2015
The company provides information on and access to high-quality offline services such as cleaning, moving, babysitting, beauty care, and many other categories in approximately 30 cities in China. With its location-based order processing system, 58 Home's platform directly connects customers to the nearest independent service providers. Founded in September 2014, 58 Home is a multi-category local services platform in China.

Zhangshang Tangyi

Series A in 2015
Zhangshang Tangyi is a health management platform with a focus on diabetes. It allows patients to upload their own health data to their mobile app and receive treatment guidance from doctors. Zhangshang Tangyi was founded in 2014 and is based in Hangzhou, Zhejiang.

Clinicloud

Seed Round in 2015
CliniCloud was founded by Dr. Hon Weng Chong and Dr. Andrew Lin, two physicians who have been friends since medical school. They realized that today’s patients are starting to play a more active role in their own care, and wanted to equip everyone with the right tools to make better healthcare decisions. CliniCloud started life as “StethoCloud, the Smart Stethoscope”, which won the 2012 Imagine Cup grant and was covered in Bloomberg, Wired, CNET, TechCrunch and others. The non-contact thermometer was added after we recognized that temperature was also a crucial data point for diagnostic decisions. After two years of hard work, we are proud to announce our first commercial product and will continue to innovate with our software and devices to bring the future of healthcare home.

Ativa Medical

Series B in 2015
Ativa Medical is a medical device manufacturing company that is working to make diagnostic test results available in moments, rather than hours and days. The company specializes in the fields of medical device development, point of care diagnostics, microfluidics, and hematology. The company was founded in 2008 and headquartered in Saint Paul, Minnesota.

Payoneer

Series E in 2015
Payoneer is a financial technology company that enables small and medium-sized enterprises to transact and thrive.
Beijing Express Channel Cold Chain Logistics provides logistics solutions. They offer cold chain urban distribution, cold chain less-than-truckload, and cold chain home delivery businesses. They provide customers with economical and suitable cold-chain logistics solutions.

Secoo

Series E in 2015
Secoo is a comprehensive luxury products and services platform based in China, facilitating global trade between buyers and suppliers. The company operates offline stores and an online mall to serve customers directly. Secoo plans to establish exhibition centers in major cities like Beijing, Shanghai, and Hong Kong. In 2011, the company generated over a hundred million RMB and boasts a membership base of 500,000, including more than 20,000 VIPs. In late 2010, Secoo secured a $10 million investment from IDG, followed by a $30 million investment from leading international funds.

Didi

Private Equity Round in 2015
Didi Chuxing is a mobile transportation platform that offers app-based transportation services. The company offers a mobile tech-based mobility option for users across, including taxi-hailing, private car-hailing, Hitch (social ride-sharing), DiDi Chauffeur, DiDi Bus, DiDi Test Drive, DiDi Car Rental, and DiDi Enterprise Solutions. As a practitioner in the sharing economy initiative, DiDi is committed to working with communities and partners to solve transportation, environmental challenges, and employment problems using big data-driven deep-learning algorithms that optimize resource allocation.

Bochewang

Series A in 2015
Bochewang is a professional B2B trading platform for motor cars and accessories, offering a plethora of vehicle sources, accessories, and high-quality services to professional buyers such auto repair shops, dismantle shops, used car dealers, and parts sellers. The auction center, automobile showroom, and accessories platform are the three main sections of the Bochewang Auction App. Members can use the auction center to sell accident automobiles and used cars, trade repaired used cars in the vehicle showroom, and trade various sorts of auto parts on the accessories platform. To enjoy numerous services and rights, users only need to complete registration, payment, and authentication.

Rogrand

Series A in 2015
Beijing Rogrand E-Commerce Co., Ltd. is a leading pharmaceutical entire integration of industry chain service platform in China leading the innovation of new pharmaceutical business model. Since its inception in 2012, the company has always been driven by the goal of forging a circulation platform for the whole industry consisting of pharmaceutical industry, pharmaceutical business, pharmacy, clinic and medical institution.

Purple Clinic

Series A in 2015
Purple Clinic builds a WeChat doctor-patient service platform that provides solutions according to the individual needs of medical partners.

Medbanks

Series A in 2015
Medbanks Network Technology provides data processing services to the healthcare industry. It develops an oncology database of clinical and professional medical services using information collected from hospitals. It was founded in 2014 and is based in Beijing.

eXiche

Series A in 2015
eXiche provide users with Internet booking to the shop car wash, door car wash services.

9F Group

Series B in 2015
9F Fintech Holdings Group is a Chinese Fintech platform and has more than 68 million registered users with most of them using 9F’s mobile applications. Founded in 2006, 9F is committed to offering its users with simple, efficient, high-quality and comprehensive financial services and aimed to create a wealth of values for its users through mobile Internet and Big Data risk management technologies. With its many brands such as 9F Onecard, 9F Wallet, Wukong Wealth, 9F Primasia Securities, 9FChaoneng (3C at POS), LabiFenqi (Education), and Wecash, 9F Group offers an extensive range of services that cover the various needs of its member life stages. In addition, through "Jiuchuang Fund," 9F has invested into over ten Internet finance start-ups to explore future technologies and developments. 9F was a founding member of National Internet Finance Association of China (NIFA) and elected to be a board member of NIFA. Sponsored by the People’s Bank of China, the China Banking Regulatory Commission (CBRC), China Securities Regulatory Commission (CSRC) and China Insurance Regulatory Commission (CIRC), NIFA was founded in Shanghai in March 2016.

Rainbow Medical

Venture Round in 2015
Rainbow Medical is a unique private operational company that seeds and grows companies developing breakthrough medical devices invented by Yossi Gross in a diverse range of medical fields. By addressing significant unmet market needs, Rainbow Medical seeks to generate exceptional returns for its investors.

Wanjianglong

Series A in 2015
Wanjianglong is involved in the business of the internet and commercial real estate. They offer an operations service solution that covers all the needs of commercial real estate construction, opening, and operation periods, helping commercial complexes to attract newcomers, promote activation, retain customers, and increase sales.

Qukaidan

Series B in 2014
Enterprise service

Mogoroom

Series A in 2014
Mogoroom currently operates in Shanghai and Beijing, providing standardized rental apartments to young professionals seeking more convenient living environment services.

Qiaobu Jianli

Series A in 2014
Qiaobu Jianli provides online portal services for resume templates to students. They offer black and white resume templates and colour resume templates. Thye also offer industries related resume templates such as communication , biology, pharmaceutical, civil engineering.

eToro

Series D in 2014
EToro is a social trading and investment network that allows users to trade currencies, commodities, indices, crypto assets, and stocks. It is a multi-asset investment platform that empowers people to grow their knowledge and wealth as part of a global community.

Black & White Campus

Angel Round in 2014
Black and White Campus offers campus promotion activities.

Prime Cloud

Series A in 2014
Prime Cloud is a cloud service company that focuses on desktop cloud, education informatization and cloud platforms.

Goku remote control

Angel Round in 2014
Goku remote control combines TV features including live broadcast, on-demand, and application installation and transforms the phone into a remote control.

Payoneer

Series D in 2014
Payoneer is a financial technology company that enables small and medium-sized enterprises to transact and thrive.

Xieche.com

Series A in 2014
Xieche is a provider of automobile maintenance and repair services for car owners. They cover various car repair and maintenance projects such as sheet metal painting, electromechanical repair, and maintenance. They provide car maintenance services of maintenance at home, and repair at the store.

75wan.cn

Series A in 2014
75wan.cn is a mobile game development and distribution company.

JMDNA

Series A in 2014
JMDNA is a high-tech enterprise focusing on new technology research and clinical application in the field of women and children. It provides comprehensive, individualized, and precise genetic testing services for medical institutions and industry partners.

Lewanduo

Angel Round in 2014
Lewanduo is a distributor and operator of mobile games.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.